Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2229582 | 0.78 | FDPS (0.46) | ALDH1A1LMNAMAPT | |
| SCHEMBL2232026 | 0.77 | CYP2D6 (0.53) | ALDH1A1LMNAMAPT | |
| SCHEMBL2945432 | 0.73 | — | — | |
| SCHEMBL4953332 | 0.69 | DPP4 (0.34) | — | |
| SCHEMBL2230154 | 0.69 | DPP4 (0.34) | — | |
| SCHEMBL13069245 | 0.69 | DPP4 (0.34) | — | |
| SCHEMBL4953344 | 0.69 | DPP4 (0.34) | — | |
| SCHEMBL6380793 | 0.69 | TSHR (0.33) | ALDH1A1LMNA | |
| SCHEMBL15129648 | 0.67 | — | — | |
| SCHEMBL15129418 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200970-B1 | ALDEHYDES CONTAINING HYDROXYL GROUPS | SIKA TECHNOLOGY AG (CH) | 2016-01-06 | — | — | EP | disclosed |
| US-8455100-B2 | Aldimines comprising hydroxyl groups, and compositions containing aldimine | SIKA TECHNOLOGY AG (CH) | 2013-06-04 | — | — | US | disclosed |
| US-8389772-B2 | Aldehydes containing hydroxl groups | SIKA TECHNOLOGY AG (CH) | 2013-03-05 | — | — | US | disclosed |
| US-20110195242-A1 | ALDEHYDES CONTAINING HYDROXL GROUPS | SIKA TECHNOLOGY AG (CH) | 2011-08-11 | — | — | US | disclosed |
| EP-2200973-B1 | ALDIMINES COMPRISING HYDROXYL GROUPS, AND COMPOSITIONS CONTAINING ALDIMINE | SIKA TECHNOLOGY AG (CH) | 2011-07-13 | — | — | EP | disclosed |
| US-20100190014-A1 | ALDIMINES COMPRISING HYDROXYL GROUPS, AND COMPOSITIONS CONTAINING ALDIMINE | SIKA TECHNOLOGY AG (CH) | 2010-07-29 | — | — | US | disclosed |
| EP-2200973-A1 | ALDIMINES COMPRISING HYDROXYL GROUPS, AND COMPOSITIONS CONTAINING ALDIMINE | Sika Technology AG (CH) | 2010-06-30 | — | — | EP | disclosed |
| EP-2200970-A1 | ALDEHYDES CONTAINING HYDROXYL GROUPS | Sika Technology AG (CH) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009027510-A1 | ALDEHYDES CONTAINING HYDROXYL GROUPS | SIKA TECHNOLOGY AG (CH) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009027511-A1 | ALDIMINES COMPRISING HYDROXYL GROUPS, AND COMPOSITIONS CONTAINING ALDIMINE | SIKA TECHNOLOGY AG (CH) | 2009-03-05 | — | — | WO | disclosed |
| EP-2030965-A1 | Aldehydes containing hydroxyl groups | Sika Technology AG (CH) | 2009-03-04 | — | — | EP | disclosed |
| EP-2030967-A1 | Aldimines containing hydroxyl groups and compositions containing aldimine | Sika Technology AG (CH) | 2009-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195242-A1 | ALDEHYDES CONTAINING HYDROXL GROUPS | ALDH7A1, ALDH1A1, AOX1 | ALDH1A1 2/4885LMNA 1740/4885MAPT 1835/4885 |
| US-20100190014-A1 | ALDIMINES COMPRISING HYDROXYL GROUPS, AND COMPOSITIONS CONTAINING ALDIMINE | ADH5, ADH1A, ADH1C | ALDH1A1 6/4885LMNA 1423/4885MAPT 1624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.